Search peptides, terms, sources/
Research source · 2017

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Adults with obesity and prediabetes
Sample size
2,254 randomised 2:1
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Sponsor-funded (Novo Nordisk). Only 50% of participants completed the 160-week trial.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.